Thromboembolic Diseases During Pregnancy: Prevention And Management
Susmitha G
11 views
Pregnancy is a period of wonder, anticipation, and vulnerability. Amid the excitement of new life, clinicians must also guard against silent but serious threats. One of these is venous thromboembolism (VTE), a clotting disorder that, if unchecked, can turn a routine pregnancy into a life-threatening situation. The good news? With vigilant risk assessment, preventive strategies, and evidence-based management, we can dramatically reduce harm. But to do so, obstetricians and maternal medicine specialists must stay current — and that means upskilling in thromboembolic care is not optional.
In this blog, we will unpack the mechanisms, risk factors, diagnostic challenges, and therapeutic pathways for thromboembolic disease in pregnancy. We’ll also reflect on how advanced upskilling (such as a Fellowship in Gynecology & Obstetrics) can equip you to lead safe and modern obstetric care. Let’s begin.
The Physiology Behind Hypercoagulability
Pregnancy is nature’s paradox: a state of increased bleeding risk (at delivery) paired with a strong pro-coagulant shift to protect against hemorrhage. As gestation advances, plasma concentrations of clotting factors (I, VII, VIII, IX, X, XII) rise; fibrinogen may increase up to threefold. Meanwhile, natural anticoagulants such as protein S decline, and fibrinolytic activity is suppressed via elevated levels of plasminogen activator inhibitors (PAI-1 and PAI-2). These shifts tilt the balance toward clot formation.
Additionally, mechanical venous stasis plays a role. An expanding uterus compresses pelvic veins, slowing venous return, especially in the left lower extremity. Endothelial injury, when present, further increases thrombotic risk. Collectively, this “Virchow’s triad” is amplified in pregnancy.
Identifying High-Risk Women: Risk Stratification
Some risk factors are intrinsic and stable; others emerge during gestation. Key risk factors include:
- Prior history of deep vein thrombosis (DVT) or pulmonary embolism (PE)
- Known thrombophilia (e.g., factor V Leiden, prothrombin G20210A, protein C or S deficiency, antithrombin deficiency)
- Obesity (BMI ≥ 30)
- Maternal age > 35 years
- Multiple gestation or hyperemesis
- Prolonged immobilization or hospitalization
- Preeclampsia, gestational diabetes, cesarean delivery
- Assisted reproductive techniques
- Antepartum bleeding or major obstetric surgery
Prevention: Prophylaxis That Saves Lives
Not every pregnant woman needs pharmacologic prophylaxis. The decision hinges on risk stratification. Women with a history of VTE or high-risk thrombophilia often merit antepartum and postpartum prophylaxis, unless contraindicated. Intermediate-risk women may receive prophylaxis only during high-risk periods (e.g., after surgery, prolonged immobilization). It’s important to balance bleeding risk. If the risk of hemorrhage is high, mechanical prophylaxis (e.g., compression stockings, pneumatic devices) may be preferred or used adjunctively.
Diagnosis Challenges & Strategies
Diagnosing VTE in pregnancy is complex because many symptoms overlap with normal physiologic changes (e.g., leg swelling, tachycardia). Clinicians must maintain a high index of suspicion.
Diagnostic Tools & Imaging
When suspicion is high, imaging is warranted. Modalities include:
- Compression ultrasonography for suspected DVT (noninvasive, no radiation)
- Ventilation–perfusion (V/Q) scan or CT pulmonary angiography (CTPA) for suspected PE — choice depends on local availability and radiation considerations
Balancing Maternal & Fetal Safety
Radiation exposure is a concern, but modern V/Q or CTPA protocols expose the fetus to relatively low doses that are generally acceptable if maternal care is at stake. The maternal benefit of diagnosing or excluding PE typically outweighs the minor fetal risk.
It’s crucial to involve a multidisciplinary team (obstetrician, maternal-fetal medicine, radiologist, hematologist) when making imaging decisions.
Management of Confirmed VTE in Pregnancy
Most women on Low-Molecular-Weight Heparin (LMWH) don’t need routine blood tests. Special monitoring may only be required in cases like very high or low body weight or kidney problems. Doctors may also check platelet counts in the early stages to rule out rare complications. Since a woman’s weight and kidney function can change during pregnancy, the dosage may need to be adjusted along the way. Managing blood thinners around the time of birth can be challenging.
Clinical Checklist: From Risk to Action
- Perform a baseline VTE risk assessment early in pregnancy, and update it in the third trimester.
- For those identified at moderate-to-high risk, consider LMWH prophylaxis, balancing bleeding risk.
- Educate patients about signs and symptoms — leg pain/swelling, sudden dyspnea, chest pain, so they present early.
- For suspected VTE, follow imaging algorithms adapted for pregnancy.
- In high-risk thrombophilia cases, engage hematology and maternal-fetal medicine for guidance.
Why Modern Clinicians Must Master Thromboembolic Care
Thromboembolic disease in pregnancy is not a theoretical curiosity. It remains a real, life-threatening challenge in obstetrics, contributing significantly to maternal morbidity and mortality. Given evolving diagnostics, prophylactic regimens, and peripartum anticoagulation strategies, clinicians must continuously update their expertise.
In many settings, gaps exist in:
- Risk assessment integration into routine antenatal workflows
- Confidence in coordinating imaging and peripartum anticoagulation
- Real-world knowledge of up-to-date guidelines
- Multidisciplinary coordination among obstetrics, hematology, and radiology
Bridging these gaps demands structured, specialty-level learning, not just passive reading of articles.
Upskilling Through Fellowship: How Medvarsity Empowers Experts
At Medvarsity, we recognize that modern Obstetrics & Gynecology demands mastery beyond clinical basics. Our Fellowship in Gynecology & Obstetrics weaves together advanced content, expert mentorship, case-based learning, and observerships to sharpen your practice.
By joining this fellowship, you become part of a community committed to excellence, evolving not only your knowledge but your ability to lead change in maternal care.
Thromboembolic diseases during pregnancy pose one of the more complex challenges in maternal medicine. But they are not unbeatable. With careful risk stratification, mindful prophylaxis, prompt diagnosis, and careful anticoagulation management, clinicians can significantly reduce harm.
In this fast-evolving era of guidelines and technologies, programs like Medvarsity’s Fellowship in Gynecology & Obstetrics can help you stay ahead with relevant knowledge.
Enquire About This Topic
Get in touch with our experts to learn more
